Back
Edesa Biotech Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
19
EDSA
Edesa Biotech
Last Price:
2.11
Seasonality Move:
5.49%
Buy
68
AUPH
Aurinia Pharmaceuticals
Last Price:
8.97
Seasonality Move:
24.51%
Sell
19
Edesa Biotech (EDSA)
is a Sell
Is Edesa Biotech a Buy, Sell or Hold?
- The current Edesa Biotech [EDSA] share price is $2.11. The Score for EDSA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- EDSA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
68
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.77. The Score for AUPH is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EDSA Stock Price Chart
What is Edesa Biotech's stock price today?
-
The Edesa Biotech share price today is $2.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDSA is experiencing slight buying pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
EDSA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 23.05 | Sell |
Chaikin Money Flow: | 1085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.24 - 3.48) | Sell |
Bollinger Bands (100): | (3.27 - 4.91) | Sell |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 71.82 | Buy |
Chaikin Money Flow: | 1867716 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.13 - 8.27) | Buy |
Bollinger Bands (100): | (5.79 - 7.57) | Buy |
EDSA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.2 | Sell |
20-day SMA: | 2.65 | Sell |
50-day SMA: | 3.59 | Sell |
200-day SMA: | 4.31 | Sell |
8-day EMA: | 2.25 | Sell |
20-day EMA: | 2.64 | Sell |
50-day EMA: | 3.32 | Sell |
200-day EMA: | 4.27 | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.28 | Buy |
20-day SMA: | 7.86 | Buy |
50-day SMA: | 7.38 | Buy |
200-day SMA: | 6.09 | Buy |
8-day EMA: | 8.28 | Buy |
20-day EMA: | 7.95 | Buy |
50-day EMA: | 7.43 | Buy |
200-day EMA: | 6.82 | Buy |
Edesa Biotech Earnings Growth & EDSA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Edesa Biotech Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |